Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models
Table 5
Area under the curve for circulating metabolites as a percentage of fosmetpantotenate (parent) after a single oral administration of 100, 300, or 700 mg/kg to mice, rats, and monkeys.